Hypoxia-Inducible Factor 1 Promoter-Induced JAB1 Overexpression Enhances Chemotherapeutic Sensitivity of Lung Cancer Cell Line A549 in an Anoxic Environment |
Hu, Ming-Dong
(Institute of Respiration, the Second Affiliated Hospital, the Third Military Medical University)
Xu, Jian-Cheng (Institute of Respiration, the Second Affiliated Hospital, the Third Military Medical University) Fan, Ye (Institute of Respiration, the Second Affiliated Hospital, the Third Military Medical University) Xie, Qi-Chao (Department of Tumors, the Second Affiliated Hospital, the Third Military Medical University) Li, Qi (Institute of Respiration, the Second Affiliated Hospital, the Third Military Medical University) Zhou, Chang-Xi (The General Hospital of PLA) Mao, Mei (Wuhan General Hospital of Guangzhou Military Regions) Yang, Yu (Institute of Respiration, the Second Affiliated Hospital, the Third Military Medical University) |
1 | Lee SH, Kim J, Kim WH, Lee YM (2009). Hypoxic silencing of tumor suppressor RUNX3 by histone modification in gastric cancer cells. Oncogene, 28, 184-94. DOI |
2 |
Liao HY, Wang GP, Gu LJ, et al (2012). HIF- |
3 | Liu X, Pan Z, Zhang L, et al (2008). JAB1 accelerates mitochondrial apoptosis by interaction with proapoptotic BclGs. Cell Signal, 20, 230-40. DOI |
4 | Livak KJ, Schmittgen TD (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods, 25, 402-8. DOI ScienceOn |
5 | Maher JC, Wangpaichitr M, Savaraj N, Kurtoglu M, Lampidis TJ (2007). Hypoxia-inducible factor-1 confers resistance to the glycolytic inhibitor 2-deoxy-D-glucose. Mol Cancer Ther, 6, 732-41. |
6 | Osoegawa A, Yoshino I, Kometani T, et al (2006). Overexpression of Jun activation domain-binding protein 1 in nonsmall cell lung cancer and its significance in p27 expression and clinical features. Cancer, 107, 154-61. DOI |
7 | Pommier Y, Sordet O, Antony S, Hayward RL, Kohn KW (2004). Apoptosis defects and chemotherapy resistance: molecular interaction maps and networks. Oncogene, 23, 2934-49. DOI ScienceOn |
8 | Post DE, Van Meir EG (2001). Generation of bidirectional hypoxia/HIF-responsive expression vectors to target gene expression to hypoxic cells. Gene Ther, 8, 1801-7. DOI |
9 | Ruan H, Su H, Hu L, et al (2001). A hypoxia-regulated adenoassociated virus vector for cancer-specific gene therapy. Neoplasia, 3, 255-63. DOI |
10 | Semenza GL (1999). Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol, 15, 551-78. DOI ScienceOn |
11 | Semenza GL (2000). HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J Appl Physiol, 88, 1474-80. DOI |
12 | Semenza GL, Jiang BH, Leung SW, et al (1996). Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J Biol Chem, 271, 32529-37. DOI |
13 | Shintani S, Li C, Mihara M, Hino S, Nakashiro K, Hamakawa H (2003). Skp2 and Jab1 expression are associated with inverse expression of p27kip1 and poor prognosis in oral squamous cell carcinomas. Oncology, 65, 355-62. DOI ScienceOn |
14 | Tamura N, Dong Y, Sui L, et al (2001). Cyclin-dependent kinase inhibitor p27 is related to cell proliferation and prognosis in laryngeal squamous cell carcinomas. J Laryngol Otol, 115, 400-6. |
15 | Toh CK (2009). The changing epidemiology of lung cancer. Methods Mol Biol, 472, 397-411. DOI ScienceOn |
16 | Tomoda K, Kubota Y, Arata Y, et al (2002). The cytoplasmic shuttling and subsequent degradation of p27kip1 mediated by JAB1/CSN5 and the COP9 signalosome complex. Biol Chem, 277, 2302-10. DOI |
17 | Tomoda K, Yoneda-Kato N, Fukumoto A, Yamanaka S, Kato JY (2004). Multiple functions of Jab1 are required for early embryonic development and growth potential in mice. J Biol Chem, 279, 43013-8. DOI ScienceOn |
18 | Wang GL, Semenza GL (1993). General involvement of hypoxiainducible factor 1 in transcriptional response to hypoxia. Proc Natl Acad Sci U S A, 90, 4304-8. DOI ScienceOn |
19 | Xie QC, Hu YD, Wang LL, et al (2005). The co-transfection of p16 (INK4a) and p14 (ARF) genes into human lung cancer cell line A549 and the effects on cell growth and chemosensitivity. Colloids Surf B Biointerfaces, 46, 188-96. DOI |
20 | Wang YC, Fei M, Cheng C, et al (2007). Jun Activation Domain- Binding Protein 1 negatively regulate p27 (kip1) in Non- Hodgkinps Lymphomas. Cancer Biol Ther, 7, 460-7. |
21 | Yang QC, Zeng BF, Shi ZM, et al (2006). Inhibition of hypoxiainduced angiogenesis by trichostatin A via suppression of HIF-1a activity in human osteosarcoma. J Exp Clin Cancer Res, 25, 593-9. |
22 | Yasuda H (2008). Solid tumor physiology and hypoxia-induced chemo/radio-resistance: novel strategy for cancer therapy: nitric oxide donor as a therapeutic enhancer. Nitric Oxide, 19, 205-16. DOI |
23 | Harrison L, Blackwell K (2004). Hypoxia and anemia: factors in decreased sensitivity to radiation therapy and chemotherapy? Oncologist, 5, 31-40. |
24 | Bando H, Toi M, Kitada K, Koike M (2003). Genes commonly upregulated by hypoxia in human breast cancer cells MCF-7 and MDA-MB-231. Biomed Pharmacother, 57, 333-40. DOI |
25 | Cheah PL, Looi LM, Teoh KH, Mun KS, Nazarina AR (2012). p16INK4a is a useful marker of human papillomavirus integration allowing risk stratification for cervical malignancies. Asian Pac J Cancer Prev, 13, 469-72. DOI ScienceOn |
26 | Claret FX, Hibi M, Dhut S, Toda T, Karin M (1996). A new group of conserved coactivators that increase the specificity of AP-1 transcription factors. Nature, 383, 453-7. DOI |
27 | Dachs GU, Patterson AV, Firth JD, et al (1997). Targeting gene expression to hypoxic tumor cells. Nat Med, 3, 515-20. DOI ScienceOn |
28 | Hallstrom TC, Nevins JR (2006). JAB1 is a specificity factor for E2F1-induced apoptosis. Genes Dev, 20, 613-23. DOI |
29 |
Hayashi M, Sakata M, Takeda T, et al (2004). Induction of glucose transporter 1 expression through hypoxia-inducible factor |
30 | Kouvaraki MA, Korapati AL, Rassidakis GZ, et al (2006). Potential role of Jun activation domain-binding protein 1 as a negative regulator of P27kip1 in pancreatic adenocarcinoma. Cancer Res, 66, 8581-9. DOI |
31 | Kouvaraki MA, Rassidakis GZ, Tian L, et al (2003). Jun activation domain-binding protein 1 expression in breast cancer inversely correlates with the cell cycle inhibitor p27kip1. Cancer Res, 63, 2977-81. |
32 | Lara PC, Lloret M, Clavo B, et al (2009). Severe hypoxia induces chemo-resistance in clinical cervical tumors through MVP over-expression. Radiat Oncol, 4, 29. DOI |
![]() |